Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ProQR Therapeutics NV announced that its investigational therapy AX-422 for mucopolysaccharidosis type I (MPS1) is expected to submit a Clinical Trial Application (CTA) in early 2027.

ProQR Therapeutics NV announced that its investigational therapy AX-422 for mucopolysaccharidosis type I (MPS1) is expected to submit a Clinical Trial Application (CTA) in early 2027.

老虎证券老虎证券2026/06/25 10:37
Show original
The company further stated that preliminary data from the trial is expected to be available in the first half of 2027.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Bank of America survey: Long semiconductors remains the world's most crowded trade, but the level of crowding has nearly halved from the July peak

A Bank of America survey shows that 39% of fund managers consider going long on semiconductors to be the most crowded trade. Although it remains the top position, this figure has dropped significantly from the July peak of 82%, indicating that positions are starting to loosen.

智通财经•2026/11/18 08:11

Energy shock not widespread? UK inflation hits one-year high but falls short of central bank expectations, traders scale back rate hike bets

Driven by a sharp increase in energy bills and vehicle fuel prices, inflation in the UK has accelerated, reaching its highest level in a year.

智通财经•2026/11/18 08:11
Energy shock not widespread? UK inflation hits one-year high but falls short of central bank expectations, traders scale back rate hike bets